$AMRX
Amneal Pharmaceuticals, Inc.

2024 Q3 Form 10-Q Financial Statement

#000172312824000032 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $702.5M $701.8M
YoY Change 13.29% 17.15%
Cost Of Revenue $432.9M $451.8M
YoY Change 11.72% 19.21%
Gross Profit $269.6M $249.9M
YoY Change 15.92% 13.6%
Gross Profit Margin 38.37% 35.62%
Selling, General & Admin $118.7M $116.5M
YoY Change 5.03% 10.32%
% of Gross Profit 44.03% 46.59%
Research & Development $61.10M $36.05M
YoY Change 47.67% -4.62%
% of Gross Profit 22.67% 14.42%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $179.8M $152.5M
YoY Change 16.46% 6.38%
Operating Profit $88.81M $95.47M
YoY Change 17.4% 19.21%
Interest Expense -$65.51M -$65.72M
YoY Change 28.68% 29.22%
% of Operating Profit -73.77% -68.84%
Other Income/Expense, Net -$73.39M -$75.07M
YoY Change 39.28% 48.87%
Pretax Income $15.42M $20.41M
YoY Change -32.82% -31.2%
Income Tax $3.700M $3.600M
% Of Pretax Income 23.99% 17.64%
Net Earnings -$156.0K $5.994M
YoY Change -101.0% -73.04%
Net Earnings / Revenue -0.02% 0.85%
Basic Earnings Per Share $0.00 $0.02
Diluted Earnings Per Share $0.00 $0.02
COMMON SHARES
Basic Shares Outstanding 309.5M shares 308.7M shares
Diluted Shares Outstanding 309.6M shares 319.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $74.01M $43.77M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $596.4M $575.6M
Prepaid Expenses
Receivables
Other Receivables $7.855M $7.885M
Total Short-Term Assets $1.513B $1.485B
YoY Change 3.93% 4.48%
LONG-TERM ASSETS
Property, Plant & Equipment $431.0M $425.4M
YoY Change -4.61% -7.35%
Goodwill $598.3M $598.5M
YoY Change -0.05% -0.11%
Intangibles $780.2M $819.9M
YoY Change -20.59% -19.25%
Long-Term Investments
YoY Change
Other Assets $36.27M $77.03M
YoY Change -59.26% -17.39%
Total Long-Term Assets $1.948B $2.024B
YoY Change -12.7% -11.17%
TOTAL ASSETS
Total Short-Term Assets $1.513B $1.485B
Total Long-Term Assets $1.948B $2.024B
Total Assets $3.461B $3.510B
YoY Change -6.13% -5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $235.0M $199.6M
YoY Change 32.47% 43.04%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $224.7M $225.2M
YoY Change 635.9% 640.52%
Total Short-Term Liabilities $1.095B $1.114B
YoY Change 43.99% 43.35%
LONG-TERM LIABILITIES
Long-Term Debt $2.170B $2.178B
YoY Change -14.64% -14.58%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.399B $2.400B
YoY Change -12.27% -12.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.095B $1.114B
Total Long-Term Liabilities $2.399B $2.400B
Total Liabilities $3.495B $3.514B
YoY Change -0.03% -0.11%
SHAREHOLDERS EQUITY
Retained Earnings -$576.0M -$575.8M
YoY Change 47.11% 43.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$93.43M -$57.47M
YoY Change
Total Liabilities & Shareholders Equity $3.461B $3.510B
YoY Change -6.13% -5.16%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$156.0K $5.994M
YoY Change -101.0% -73.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
308198000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154575000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40100000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40800000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000000.0 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
23342000 usd
CY2023Q4 amrx Rebates And Chargebacks
RebatesAndChargebacks
10226000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
14941000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77028000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55517000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
199578000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
143572000 usd
CY2024Q2 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
142716000 usd
CY2023Q4 amrx Accrued Sales Returns Allowance Current
AccruedSalesReturnsAllowanceCurrent
136486000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60635000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71122000 usd
CY2024Q2 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
109190000 usd
CY2023Q4 amrx Accrued Sales Rebates Current
AccruedSalesRebatesCurrent
90690000 usd
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
26325000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48219000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2514230000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2543626000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
111496000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
123497000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2402734000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2420129000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
225156000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34125000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2177578000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2386004000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1114353000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
846595000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2177578000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2386004000 usd
CY2024Q2 us-gaap Other Notes Payable
OtherNotesPayable
0 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
41447000 usd
CY2024Q2 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
85479000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
316000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2399636000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2564670000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
53422000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
41293000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545701000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
539240000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-575825000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-490176000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30436000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32349000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-57465000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19781000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-24000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
230000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57489000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20011000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3509922000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3472569000 usd
us-gaap Profit Loss
ProfitLoss
-64891000 usd
us-gaap Profit Loss
ProfitLoss
19589000 usd
amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
111100000 usd
amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
115261000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2080000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1561000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1221000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4523000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
920000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1283000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3907000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13446000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14157000 usd
us-gaap Inventory Write Down
InventoryWriteDown
41493000 usd
us-gaap Inventory Write Down
InventoryWriteDown
41806000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1531000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3364000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
155843000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66976000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35447000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
60526000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8418000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-31898000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
628000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-351000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
122026000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-107760000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
9619000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
2913000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35247000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
128367000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19824000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21691000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10450000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1488000 usd
amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
940000 usd
amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
842000 usd
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
4989000 usd
us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26225000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24021000 usd
CY2024Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-92000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-170000 usd
CY2024Q2 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
4512000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6516000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57489000 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
53422000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20011000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
41293000 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-85903000 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
21012000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-429000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13446000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
386000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-7342000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
15373000 usd
amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
8883000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
13031000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57489000 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
53422000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134668000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
27527000 usd
CY2023Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
22232000 usd
CY2023Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
7451000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
260000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6561000 usd
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-62000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
8312000 usd
CY2023Q2 amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
21203000 usd
CY2023Q2 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
2872000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150768000 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
32106000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
183979000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
24949000 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
6601000 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
12988000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
2057000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14157000 usd
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2057000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-5958000 usd
amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
48011000 usd
amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
5831000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
150768000 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
32106000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:106%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, valuation of intangible and other assets acquired in business combinations, allowances for accounts receivable, accrued liabilities, liabilities for legal matters, contingent liabilities, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prior period balances related to the TRA (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 5. Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of $0.4 million and $1.2 million, formerly included in other income, net for the three and six months ended June 30, 2023, respectively, have been reclassified to the income statement caption “increase in tax receivable agreement liability” to conform to the current period presentation in the consolidated statements of operations. This reclassification did not impact total other expense, net or net income (loss).</span></div>The prior period balance related to long-term liabilities for legal matters of $0.3 million, formerly included in other long-term liabilities as of December 31, 2023, has been reclassified to the balance sheet caption “liabilities for legal matters - long term” to conform to the current period presentation in the consolidated balance sheets. This reclassification did not impact total long-term liabilities or total liabilities
CY2023Q2 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-400000 usd
amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-1200000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
300000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
701780000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
599046000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1360971000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1156586000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3600000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.177
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9800000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.177
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
565700000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
566500000 usd
CY2018 amrx Tax Receivable Agreement Payment Ratio
TaxReceivableAgreementPaymentRatio
0.01
CY2018 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2019Q1 amrx Reversal Of Accrued Tax Receivable Agreement Liability
ReversalOfAccruedTaxReceivableAgreementLiability
192800000 usd
amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2023Q4 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.75
CY2023Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
185000000 usd
CY2024Q2 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
185000000 usd
CY2024Q2 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
19100000 usd
CY2023Q4 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
3800000 usd
CY2024Q2 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-13400000 usd
CY2023Q2 amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-400000 usd
amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-15400000 usd
amrx Increase Decrease In Tax Receivable Agreement Liability
IncreaseDecreaseInTaxReceivableAgreementLiability
-1200000 usd
CY2024Q2 amrx Tax Receivable Agreement Liability
TaxReceivableAgreementLiability
19100000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5994000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11917000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-85649000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4974000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309117000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153738000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
308198000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152928000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
318957000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154887000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1240341000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1199980000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2719000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3022000 usd
CY2024Q2 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
442303000 usd
CY2023Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
559334000 usd
CY2024Q2 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
25448000 usd
CY2023Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
23892000 usd
CY2024Q2 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
470470000 usd
CY2023Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
586248000 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
199696000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
217744000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49165000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59563000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
326763000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
304077000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
575624000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
581384000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3446000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2200000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
5666000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
8334000 usd
CY2024Q2 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
2424000 usd
CY2023Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
6331000 usd
CY2024Q2 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
10315000 usd
CY2023Q4 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
13168000 usd
CY2024Q2 us-gaap Prepaid Taxes
PrepaidTaxes
10910000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
11899000 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7885000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9929000 usd
CY2024Q2 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
6540000 usd
CY2023Q4 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
7876000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
34410000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
22948000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
81596000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
82685000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
598853000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-224000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
598629000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-96000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
598533000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1319769000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
855670000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
464099000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1310771000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
776193000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
534578000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355845000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1675614000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
855670000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
819944000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666616000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
776193000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
890423000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81900000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
355800000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
79672000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
121738000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
73215000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
52706000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33363000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
26517000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
76888000 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q2 amrx Rebates And Chargebacks
RebatesAndChargebacks
10226000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
11005000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55583000 usd
CY2024Q2 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
52462000 usd
CY2024Q2 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
8408000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1021000 usd
CY2023Q4 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
37089000 usd
CY2023Q4 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
9100000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
921000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
6500000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
13000000.0 usd
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
19100000 usd
CY2024Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
36100000 usd
CY2024Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-700000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-95100000 usd
CY2024Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
30740000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
76988000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
21200000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
48000000.0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
amrx Number Of Products Families
NumberOfProductsFamilies
270 product
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
701780000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
451833000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
249947000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116462000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36054000 usd
CY2024Q2 us-gaap Royalty Expense
RoyaltyExpense
1042000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
220000 usd
CY2024Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-699000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
95470000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-13000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80084000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1156586000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
758379000 usd
us-gaap Gross Profit
GrossProfit
398207000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207666000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76489000 usd
us-gaap Royalty Expense
RoyaltyExpense
2464000 usd
us-gaap Restructuring Charges
RestructuringCharges
592000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3907000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1581000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1211000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
114533000 usd

Files In Submission

Name View Source Status
0001723128-24-000032-index-headers.html Edgar Link pending
0001723128-24-000032-index.html Edgar Link pending
0001723128-24-000032.txt Edgar Link pending
0001723128-24-000032-xbrl.zip Edgar Link pending
amrx-20240630.htm Edgar Link pending
amrx-20240630.xsd Edgar Link pending
amrx-2024063010xqexx311.htm Edgar Link pending
amrx-2024063010xqexx312.htm Edgar Link pending
amrx-2024063010xqexx313.htm Edgar Link pending
amrx-2024063010xqexx321.htm Edgar Link pending
amrx-2024063010xqexx322.htm Edgar Link pending
amrx-2024063010xqexx323.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
amrx-20240630_def.xml Edgar Link unprocessable
amrx-20240630_lab.xml Edgar Link unprocessable
amrx-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amrx-20240630_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
amrx-20240630_cal.xml Edgar Link unprocessable